EN DE

Youngbo Chemical Co (014440) Fair Value & Analysis

Basic Materials · KR · Market cap 88.4B KRW

YC Youngbo Chemical Co 014440 · KO
Price4,590 KRW
Fair Value5,471 KRW
Upside+19.2%
Quality60/100
Watch Youngbo Chemical Co for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Solidly profitable · 13.5% net margin
Low debt · generates free cash flow
7.78% dividend yield
Ranks above peers (10/10)
Moderate moat 50/100
Evidence: High Range 4,818 KRW – 8,093 KRW Share as image

Fair value as of: Jul 24, 2026

From 24 valuation models · updated 18 days ago

Fair value updated Jul 24, 2026, revised from 9,842 KRW to 5,471 KRW (−44.4%) since Jun 25, 2026. Share price +0.7% over the past month.

A solid business, screening 19% undervalued on our models.

What matters now

  • The price is below even our cautious bear case (4,818 KRW). The market is more pessimistic than our downside scenario.
  • Our model range runs from 4,818 KRW (bear) to 8,093 KRW (bull), base 5,471 KRW. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 60/100 (solid quality) with high evidence: the data supports the verdict.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

5,441 KRW 2,615 KRW Fair Value 5,471 KRW Mar 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 24, 2026.

How to read this chart

60‑month range 2,615 KRW – 5,441 KRW · fair‑value band 4,818 KRW – 8,093 KRW · the 4,590 KRW price screens below the 5,471 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 24, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Youngbo Chemical Co (014440) currently trades at 4,590 KRW, while our model-based Fair Value estimate is 5,471 KRW, implying the stock looks roughly 19.2% undervalued today. The Quality Score stands at 60/100 (solid quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Youngbo Chemical Co generated revenue of 122B KRW at a net margin of 13.5%. Revenue grew 7.5% year over year. It earns a return on equity of 8.9%. Fundamentals as of Jul 24, 2026

Our scenario range runs from 4,818 KRW (bear case) to 8,093 KRW (bull case); at 4,590 KRW, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 13% below its 52-week high and 17% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -46% fair-value upside, at 19%, 014440 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 4,364 KRW 5,828 KRW 8,366 KRW 80
Residual Income 8,368 KRW 9,108 KRW 11,740 KRW 76
Rev-Margin DCF 5,431 KRW 8,275 KRW 11,741 KRW 74
All 24 models by family
DCF Models
FCF DCF 4,186 KRW 5,692 KRW 8,523 KRW 38
Owner Earnings 9,384 KRW 12,888 KRW 19,477 KRW 31
5Y Revenue Exit 5,431 KRW 8,184 KRW 12,217 KRW 39
5Y EBITDA Exit 7,498 KRW 11,748 KRW 17,410 KRW 41
5Y P/E Exit 7,583 KRW 11,895 KRW 17,060 KRW 38
10Y Revenue Exit 4,741 KRW 6,804 KRW 9,078 KRW 36
10Y EBITDA Exit 6,169 KRW 9,033 KRW 12,178 KRW 37
10Y P/E Exit 6,221 KRW 9,125 KRW 11,969 KRW 35
Earnings-Based
Graham-Dodd 5,869 KRW 7,595 KRW 8,687 KRW 54
EPV 8,748 KRW 10,161 KRW 11,398 KRW 59
Dividend Discount
Gordon GGM 3,214 KRW 3,518 KRW 3,981 KRW 70
DDM Multi-Stage 3,214 KRW 4,075 KRW 5,254 KRW 61
Multiples
P/E Multiple 11,004 KRW 14,672 KRW 18,340 KRW 63
P/S Multiple 6,929 KRW 9,239 KRW 11,549 KRW 58
P/B Multiple 11,004 KRW 14,672 KRW 18,340 KRW 55
EV/EBIT 10,656 KRW 14,118 KRW 17,580 KRW 53
EV/EBITDA 11,112 KRW 14,727 KRW 18,341 KRW 54
EV/Revenue 6,737 KRW 9,509 KRW 12,281 KRW 43
Asset-Based
NCAV (Graham) 4,905 KRW 6,573 KRW 9,810 KRW 50
Growth DCF
Growth DCF 4,364 KRW 5,828 KRW 8,366 KRW 80
Rev-Margin DCF 5,431 KRW 8,275 KRW 11,741 KRW 74
Economic Profit
Residual Income 8,368 KRW 9,108 KRW 11,740 KRW 76
ROIC Compounder 8,748 KRW 10,213 KRW 11,893 KRW 72
Growth Earnings
Growth-Adj P/E 7,839 KRW 11,199 KRW 14,559 KRW 68

Widest divergence: Multiples (14,118 KRW) versus Dividend Discount (3,518 KRW). Highest evidence: Growth DCF (80).

Notify me when 014440 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 122B KRW
Revenue growth (YoY) +7.5%
Net margin 13.5%
Return on equity 8.9%
Free cash flow 7.8B KRW FY2025
Operating margin 11.1%
More key figures
Dividend yield 7.8%
EPS growth (YoY) -10.9%

Figures from reported company fundamentals · as of Jul 24, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 60/100

Of which business quality 58 · Market factors (momentum, volatility) 58

Profitability 45
Margins and returns on capital today
Quality Growth 41
Are margins and returns improving?
Cashflow 36
Earnings quality: real cash, not paper profit
Fin. Strength 82
Balance sheet, leverage, solvency risk
Investment 72
Disciplined investing over empire-building
Low Volatility 94
Calm price path (market factor)
Momentum 40
Price trend over the last 3–12 months (market factor)
52W Momentum 46
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Youngbo Chemical Co., Ltd. manufactures and sells cross-linked polyolefin foam in Korea and internationally. The company offers artilon, epilon, filmy, and youngboard polyolefin foam products.

Full company description

Youngbo Chemical Co., Ltd. manufactures and sells cross-linked polyolefin foam in Korea and internationally. The company offers artilon, epilon, filmy, and youngboard polyolefin foam products. Its products are used in various applications, including automotive Material Parts, including instrumental panels, bumper protector, door trim, head liner, foam duct, PP board, pillar trim, evaporator insulation, sun visor, water shield, PE pad, and console armrest cover; Electronic Material Parts, such as mobile tap, TV and monitor sealing, panel protection sheet, packaging semiconductor components, metal plating sealing shielding, solar module sealing and fixing tape, pipe insulation, and home appliances molded products; and other industry products comprises insulation, packing supplies, packaging cushioning material, automative emblem guide, sports goods water play equipment, sports goods protector, sports goods cold weather supplies, mats, household goods, footwear, industrial tape, and medical accessary tape. The company was founded in 1979 and is headquartered in Chungju-si, South Korea.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Youngbo Chemical Co reported revenue of 120B KRW in FY2025 versus 99.7B KRW in FY2021, a compound +4.8%/yr. Reported net income was 16.8B KRW in FY2025, compounding +48.1%/yr from FY2021.

Growth Quality 45/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
120B KRW
Latest YoY
+2.2%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+13.1%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+2.3%
Avg. growth/yr (18Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+1.3%
Revenue +4.8%/yr
FY21 99.7B KRW
FY22 83.0B KRW
FY23 90.3B KRW
FY24 118B KRW
FY25 120B KRW
Net income +48.1%/yr
FY21 3.5B KRW
FY22 6.7B KRW
FY23 6.0B KRW
FY24 22.6B KRW
FY25 16.8B KRW

Watch 014440: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Youngbo Chemical Co Fair Value". https://www.fairvalue-calculator.com/stock/014440

Peer Group

Chemicals · 334 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 60 · Above median
Fair Value upside +19% · Top 25%
Return on equity (TTM) 9% · Above median
Return on assets 6% · Top 25%
Net margin (TTM) 13% · Top 25%
Operating margin (TTM) 11% · Above median
Revenue growth 8% · Above median
Dividend yield (TTM) 7.8% · Top 25%
Debt / equity 0.01× · Lower than 75% of peers

Valuation Multiples vs Chemicals median · lower = cheaper

P/FCF 0.0× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 59 · sector 0
FUTURE 38 · sector 20
PAST 35 · sector 19
HEALTH 99 · sector 94
DIVIDEND 100 · sector 28

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 24, 2026).

Stock Price Fair Value vs Fair Value
BASF SE BASN 1,034 MXN 532.13 MXN -49%
Ningxia Baofeng Energy Group 600989 ¥20.32 ¥20.17 -1%
Zhejiang Juhua Co 600160 ¥42.85 ¥23.35 -46%
PT Barito Pacific Tbk, BRPT 1,690 IDR 1,628 IDR -4%
LG Chem, Ltd 051910 260,500 KRW 587,755 KRW +126%
Formosa Chemicals & Fibre Corporation 1326 66.10 TWD 6.79 TWD -90%
PTT Global Chemical Public Company PTTGC 35.50 THB 18.21 THB -49%
542812 542812 ₹4,369 ₹791.05 -82%
Indorama Ventures Public Company IVL 24.50 THB 17.95 THB -27%
Navin Fluorine International Limited NAVINFLUOR ₹8,650 ₹2,146 -75%

Compare Youngbo Chemical Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Youngbo Chemical Co (014440) overvalued or undervalued?
As of Jul 24, 2026, our model estimates a fair value of 5,471 KRW versus a price of 4,590 KRW, about +19% (undervalued).
What is the fair value of 014440?
Our model-based fair value for Youngbo Chemical Co is 5,471 KRW (as of Jul 24, 2026), built from audited fundamentals. The current price is 4,590 KRW.
What is the quality score of 014440?
Youngbo Chemical Co has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Youngbo Chemical Co (014440)?
Youngbo Chemical Co reported trailing-twelve-month revenue of about 122B KRW (latest available figure, as of Jul 24, 2026).
What is the net profit margin of 014440?
The net profit margin of Youngbo Chemical Co is about 13.5%, meaning it keeps roughly 13.5% of revenue as net income. Based on the latest reported figures.
Does Youngbo Chemical Co pay a dividend?
Youngbo Chemical Co currently shows a dividend yield of about 7.60% relative to its recent price (as of Jul 24, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Youngbo Chemical Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.